DL-Butyrine

We are DL-Butyrine CAS:2835-81-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: α-aminobutyric acid
CAS.NO:2835-81-6
Synonyms: 
DL-Butyrine
DL-2-Aminobutyric Acid
Butanoic acid, 2-amino-, (±)-
2-Aminobutyric Acid
2-aminobutanoic acid
alpha-aminobutyric acid
DL-Butyrine-d3
DL-2-aminobutanoic acid
H-DL-ABU-OH
homoalanine
2-aminobutanoic
DL-.α.-Amino-n-butyric acid (.β.-form)
DL-Ethylglycine
2-amino-n-butyric acid

Molecular Formula: C4H9NO2
Molecular Weight:103.12000

Physical and Chemical Properties:
Density: 1.105 g / cm3
Boiling point: 215.2ºC at 760 mmHg
Melting point: 291-293ºC (dec.)
Flash point: 83.9ºC
Refractive index: 1.438

Specification:
Appearance:White crystalline powder
Purity:≥98%
mpurity: 0.01%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:
Intermediates of Levetiracetam  CAS:102767-28-2

Related News: Complete the research and development of APIs and intermediates, design new patented process routes, and explore new crystal forms.2-Bromo-4-fluorotoluene CAS:1422-53-3 Complete the research and development of APIs and intermediates, design new patented process routes, and explore new crystal forms.55758-02-6 The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.Di(pyrrolidin-1-yl)methanone The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list.